Wall Street analysts predict that RTI Surgical, Inc. (NASDAQ:RTIX) will report earnings of $0.01 per share for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for RTI Surgical’s earnings, with the lowest EPS estimate coming in at $0.00 and the highest estimate coming in at $0.02. The firm is scheduled to issue its next quarterly earnings report on Tuesday, October 24th.

On average, analysts expect that RTI Surgical will report full year earnings of $0.05 per share for the current year, with EPS estimates ranging from $0.04 to $0.06. For the next fiscal year, analysts anticipate that the firm will post earnings of $0.13 per share, with EPS estimates ranging from $0.10 to $0.19. Zacks’ EPS averages are a mean average based on a survey of research analysts that cover RTI Surgical.

RTI Surgical (NASDAQ:RTIX) last posted its earnings results on Tuesday, August 8th. The medical equipment provider reported $0.02 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.02. The company had revenue of $72.10 million during the quarter, compared to analysts’ expectations of $70.25 million. RTI Surgical had a negative net margin of 6.53% and a positive return on equity of 2.07%. The business’s quarterly revenue was up 6.7% on a year-over-year basis.

A number of equities analysts recently weighed in on RTIX shares. BidaskClub downgraded shares of RTI Surgical from a “strong-buy” rating to a “buy” rating in a report on Tuesday, July 25th. Zacks Investment Research raised shares of RTI Surgical from a “sell” rating to a “hold” rating in a report on Friday.

TRADEMARK VIOLATION NOTICE: This report was reported by Watch List News and is owned by of Watch List News. If you are viewing this report on another site, it was copied illegally and republished in violation of United States and international copyright legislation. The legal version of this report can be viewed at https://www.watchlistnews.com/rti-surgical-inc-rtix-expected-to-announce-earnings-of-0-01-per-share/1633945.html.

Shares of RTI Surgical (NASDAQ RTIX) opened at 4.70 on Monday. The firm’s market cap is $277.46 million. RTI Surgical has a 1-year low of $2.50 and a 1-year high of $6.00. The stock’s 50 day moving average is $4.59 and its 200-day moving average is $4.86.

In related news, EVP John N. Varela purchased 12,000 shares of the business’s stock in a transaction that occurred on Friday, August 11th. The shares were bought at an average cost of $4.85 per share, with a total value of $58,200.00. Following the acquisition, the executive vice president now owns 47,998 shares of the company’s stock, valued at $232,790.30. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Nicholas J. Valeriani purchased 5,500 shares of the business’s stock in a transaction that occurred on Monday, August 21st. The stock was bought at an average cost of $4.70 per share, for a total transaction of $25,850.00. Following the completion of the acquisition, the director now directly owns 47,754 shares in the company, valued at approximately $224,443.80. The disclosure for this purchase can be found here. 4.90% of the stock is currently owned by insiders.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in RTIX. Cigna Investments Inc. New purchased a new stake in RTI Surgical during the second quarter valued at about $105,000. Citigroup Inc. lifted its holdings in RTI Surgical by 2,850.1% during the second quarter. Citigroup Inc. now owns 21,152 shares of the medical equipment provider’s stock valued at $124,000 after purchasing an additional 20,435 shares during the last quarter. First Quadrant L P CA purchased a new stake in RTI Surgical during the second quarter valued at about $137,000. American International Group Inc. lifted its holdings in RTI Surgical by 7.0% during the first quarter. American International Group Inc. now owns 35,371 shares of the medical equipment provider’s stock valued at $141,000 after purchasing an additional 2,327 shares during the last quarter. Finally, Thompson Davis & CO. Inc. lifted its holdings in RTI Surgical by 138.8% during the second quarter. Thompson Davis & CO. Inc. now owns 25,077 shares of the medical equipment provider’s stock valued at $147,000 after purchasing an additional 14,577 shares during the last quarter. 69.99% of the stock is currently owned by institutional investors and hedge funds.

About RTI Surgical

RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.

Get a free copy of the Zacks research report on RTI Surgical (RTIX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for RTI Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.